European Pharmaceutical Strategy

by name voted on 24.11.2021

Summary

A strategic plan to make European medicines more affordable, accessible, and sustainably produced while reducing dependency on foreign suppliers.

9 24.11.2021

Other

trade

health

economy

industry

environment

social policy

administrative law

public administration

international relations

public finance and budget policy

Key points

The strategy aims to place patients at the center of all health policies, ensuring equitable access to medicines regardless of location.
There is a call to review existing regulations regarding medicines for rare diseases and children to better support these specific patient groups.
The resolution supports the full implementation of rules governing clinical trials to ensure scientific research is coordinated and transparent.
A major focus is placed on reducing the EU's dependency on non-EU countries for active pharmaceutical ingredients to prevent future shortages.

Vote

PPE

S&D

Renew

Verts/ALE

ID

ECR

The Left

NI

Total

Speeches

35 Speeches in total

Pro

Contra

Kateřina KONEČNÁ

Kateřina KONEČNÁ

The Left

1:40 min

22. A pharmaceutical strategy for Europe (debate)

João PIMENTA LOPES

João PIMENTA LOPES

The Left

1:15 min

22. A pharmaceutical strategy for Europe (debate)

Documents (PDFs)

REPORT on a pharmaceutical strategy for Europe A Pharmaceutical Strategy for Europe

These raw data are provided by the Open Data Portal of the European Union (data.europa.eu) and are licensed under ODC-BY 1.0.